NCT03315884

Brief Summary

According to the recommendations of the Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II) statement and the Russian guidelines for limb ischemia treatment (2010), reconstructive surgery is preferred for type D lesions.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Dec 2017

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 17, 2017

Completed
3 days until next milestone

First Posted

Study publicly available on registry

October 20, 2017

Completed
1 month until next milestone

Study Start

First participant enrolled

December 1, 2017

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2020

Completed
Last Updated

May 28, 2020

Status Verified

May 1, 2020

Enrollment Period

3 years

First QC Date

October 17, 2017

Last Update Submit

May 26, 2020

Conditions

Keywords

TASC C, DCFASuperailiac arteriescommon femoral arteryplasty of the common femoral arterystenting Supera

Outcome Measures

Primary Outcomes (1)

  • Primary patency of the operated segment

    during the whole period of observation. confirmation of patency of the arterial ultrasound of the operated segment. Confirmation patency of artery 24 months after surgery using Multislice computed tomography angiography of the lower extremities

    during the whole period of observation. Observation is 24 month after surgery

Secondary Outcomes (8)

  • Secondary patency of the operated artery restenosis

    during the whole period of observation. Observation is 24 month after surgery

  • reocclusion

    during the whole period of observation. Observation is 24 month after surgery

  • postoperative bleeding

    in the early postoperative period. Surveillance is 30 days after surgery

  • hematoma

    in the early postoperative period. Surveillance is 30 days after surgery

  • myocardial infarction

    during the whole period of observation. Observation is 24 month after surgery

  • +3 more secondary outcomes

Study Arms (2)

Iliac segment recanalization and stenting Iliac segment CFA

EXPERIMENTAL

Iliac segment recanalization and stenting Iliac segment Common Femoral Artery (CFA)

Procedure: Iliac segment recanalization, stenting and plastic Common Femoral Artery (CFA) patch

Iliac segment recanalization, stenting and plastic CFA patch

ACTIVE COMPARATOR

Iliac segment recanalization, stenting and plastic Common Femoral Artery (CFA) patch

Procedure: Iliac segment recanalization and stenting Iliac segment Common Femoral Artery (CFA)

Interventions

Retrograde femoral access. Brachial access. Standard endovascular access is performed under local anesthesia and affected arterial segment is visualized. Stenosis or artery occlusion is passed with hydrophilic guide. In case of occlusion transluminal or subintimal (often "mixed") artery recanalization is performed. To maximize the preservation of the affected artery initial patency, occlusion recanalization is performed by ante-and retrograde accesses. Then stenosis or occlusion predilation is performed with balloon catheter (balloon catheter diameter is smaller than the affected artery diameter for 1-2 mm). After control angiography stent is installed in the aorta-iliac area throughout the lesion (lesion diameter corresponds to the stenotic arteries diameter). In aorta-iliac zone balloon-expandable and self-expandable stents are used.

Also known as: Endovascular intervention
Iliac segment recanalization, stenting and plastic CFA patch

Standard access to the CFA is performed. Outflow ways and CFA capability for reconstruction are determined. The puncture of the general CFA (retrograde) is performed and the introducer 7Fr. is set. Recanalization of iliac artery occlusion. It is necessary to cross the iliac occlusion in a retrograde fashion first and secure aortic inflow before making the arteriotomy. An ipsilateral, a contralateral and a brachial approaches are used depending on the clinical situation. If the retrograde access to the aorta failed, you use the antegrade crossing of the iliac occlusion with no intention to reenter the lumen in the CFA. After the recanalization and balloon angioplasty of iliac artery we completed the procedure with endarterectomy of CFA, patch closure and iliac stenting. The preference is to perform endarterectomy and patch before iliac stenting because it can be difficult to access the true lumen in a difficult CFA lesion. Controlling angiography were performed. Closing approach.

Also known as: Hybrid Intervention
Iliac segment recanalization and stenting Iliac segment CFA

Eligibility Criteria

Age47 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with occlusive lesions of C and D type iliac segment and CFA lesion, and with chronic lower limb ischemia (II-IV degree by Fontaine, 4-6 degree by Rutherford), age: 47-75 years old.
  • Patients who consented to participate in this study.

You may not qualify if:

  • Chronic heart failure of III-IV functional class by New York Heart Association (NYHA) classification.
  • Decompensated chronic "pulmonary" heart
  • Severe hepatic or renal failure (bilirubin\> 35 mmol / l, glomerular filtration rate \<60 mL / min);
  • Polyvalent drug allergy
  • Cancer in the terminal stage with a life expectancy less than 6 months;
  • Acute ischemic
  • Expressed aortic calcification tolerant to angioplasty
  • Patient refusal to participate or continue to participate in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

NRICP

Novosibirsk, 630055, Russia

RECRUITING

MeSH Terms

Interventions

StentsTransdermal Patch

Intervention Hierarchy (Ancestors)

Prostheses and ImplantsEquipment and Supplies

Central Study Contacts

Vyacheslav Mitrofanov

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
NETWORK
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 17, 2017

First Posted

October 20, 2017

Study Start

December 1, 2017

Primary Completion

December 1, 2020

Study Completion

December 1, 2020

Last Updated

May 28, 2020

Record last verified: 2020-05

Locations